Medicine and Dentistry
Peritoneal Dialysis
81%
Mesenchymal-Epithelial Transition
63%
Mesothelial Cell
63%
Simvastatin
54%
Peritoneum
36%
Fibronectin
27%
Uvomorulin
27%
Therapeutic Procedure
27%
Combination Therapy
18%
Glucose
18%
Protein Expression
18%
Mevalonic Acid
18%
Peritoneal Dialysis Fluid
18%
Membrane
18%
In Vitro
9%
Morphology
9%
Cholesterol
9%
Fibroblast
9%
Pyrophosphate
9%
Dialysis Catheter
9%
Patient
9%
Cells
9%
Marker
9%
Biochemistry, Genetics and Molecular Biology
Peritoneal Dialysis
100%
Mesenchymal-Epithelial Transition
63%
Rat
63%
Simvastatin
54%
Snail
27%
Fibronectin
27%
Glucose
18%
Membrane
18%
Protein Expression
18%
Mevalonate Pathway
18%
Liquid
18%
Morphology
9%
Fibroblast
9%
Cholesterol
9%
Normal Human
9%
Dialysis
9%
Sprague Dawley Rat
9%
Small GTPase
9%
Immunofluorescence
9%
Pyrophosphate
9%
Staining
9%
Thickness
9%
Immunology and Microbiology
Peritoneal Dialysis
100%
Cells
72%
Epithelial Mesenchymal Transition
63%
Rat
63%
Peritoneum
36%
Fibronectin
27%
Snail
27%
Membrane
18%
Protein Expression
18%
Liquid
18%
Fibroblast
9%
Normal Human
9%
Morphology
9%
Sprague Dawley Rat
9%
Immunofluorescence
9%
Staining
9%
Dialysis
9%
Thickness
9%
Pharmacology, Toxicology and Pharmaceutical Science
Rat
63%
Simvastatin
54%
Statin (Protein)
36%
Fibronectin
27%
Uvomorulin
27%
Glucose
18%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
18%
Mevalonic Acid
18%
Peritoneal Dialysis Fluid
18%
Cholesterol
9%
Normal Human
9%
Dialysis
9%
Sprague Dawley Rat
9%
Pyrophosphate
9%
Neuroscience
Epithelial Mesenchymal Transition
63%
Simvastatin
54%
Western Blot
45%
Fibronectin
27%
Uvomorulin
27%
Glucose
18%
Protein Expression
18%
In Vitro
9%
In Vivo
9%
Fibroblast
9%
Cholesterol
9%
Immunofluorescence
9%
Pyrophosphate
9%